GE HealthCare (Nasdaq: GEHC) announced today that it has received FDA Premarket Authorization for Pristina Recon DL, an advanced 3D mammography image reconstruction technology. Powered by deep ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback